QC Kinetix is a rapidly expanding, top-rated regenerative medicine company providing patients with innovative, non-surgical alternatives for joint and pain relief. Founded in 2017, the company has quickly exploded on the scene, establishing a presence in over 100 cities across the nation while treating thousands of patients with its cutting-edge, non-surgical therapies.
QC Kinetix utilizes regenerative medicine treatments to harness and engage the body’s natural ability to renew itself, providing improved function while avoiding surgery for musculoskeletal discomfort.
In May 2024, QC Kinetix was recognized as one of Entrepreneur’s top 10 2024 Top New and Emerging Franchises. The magazine said the innovative company climbed five spots this year to No. 9 due to its outstanding performance in unit growth, financial strength and stability, and brand power.
The company boasted an impressive 2,111% unit growth in the last three years, putting them among the top brands.
“We’re honored to rank among some of the fastest-growing franchise brands,” said the CEO of QC Kinetix. “The recognition is a true testament to our entire team’s hard work and dedication. I’m excited to watch our brand continue to grow and push the boundaries of what’s possible in the regenerative medicine industry.”
QC Kinetix Is Backed By Industry Heavyweights
The company’s unwavering mission is to provide patients with a superior alternative for pain reduction. QC is driven by a deep-rooted desire to help people reclaim their quality of life without resorting to pain meds, surgery or steroids. They have successfully treated thousands of patients using unique biologics treatment protocols, a testament to their commitment to patient care.
The company recently hired world-renowned orthopedic surgeon Dr. Mitchell Sheinkop as the national medical director with QC Kinetix.
He enters a new era of the company, bringing over 37 years of experience in joint replacement surgery. His decision to be part of the company reflects his belief in the transformative power of regenerative medicine and his commitment to patient care.
In his new position at QC Kinetix, Dr. Sheinkop will head the medical management team, focusing on the evaluation and enhancement of protocols and spearheading research and development initiatives to keep the franchise at the cutting edge of medical innovation. He aims to incorporate physical therapy and weight loss into existing treatment frameworks to elevate patient results and overall satisfaction, positively impacting the entire brand.
As QC Kinetix begins this thrilling new phase under Dr. Sheinkop’s leadership, his extensive experience – which merges outstanding clinical achievements with a strong dedication to education and professional growth – positions Dr. Sheinkop as the perfect individual to steer QC Kinetix into new realms of achievement and creativity.
The company has the backing of prominent athletes, too, including Pro Football Hall of Famer Emmitt Smith, who serves as QC Kinetix’s national spokesperson.
“I’ve got to keep taking care of these joints,” Smith said, “no losing for this guy. When I take QC Kinetix natural supplements, it’s like – bam – Emmitt 2.0. Sometimes, you need a competitive edge.”
What Is QC Kinetix?
A medical doctor, a physician assistant, a nurse practitioner, and a business professional all walked into a room.
Armed with a vision and a dream – they needed a name for their new company and idea. They wanted to acknowledge their roots in Charlotte, North Carolina – known as “the Queen City” (QC) – and the first part of their company name was born.
Kinetix is a play on kinetic energy, which simply means being in motion. QC Kinetix aims to get people back in motion by using their cells to regenerate growth.
The founders of QC Kinetix recognized a significant opportunity to challenge traditional methods of addressing musculoskeletal pain. They envisioned a cutting-edge, safer, and healthier approach, establishing a concierge medical model that uses regenerative medicine to restore patients’ quality of life. This commitment to innovation sets QC Kinetix apart and drives their continuous efforts to push the boundaries of regenerative medicine.
Many patients struggle with pain that prevents them from enjoying activities like golfing, climbing stairs, or playing with their grandchildren. QC Kinetix offers a superior treatment method that avoids harmful medications, toxic steroid injections, and the risks associated with surgery.
“No longer did we want insurance to tell us what they were willing to pay to treat a patient,” a company spokesperson explained. “We wanted the research to tell us the most effective method, whether it was covered by insurance or not, and bring it to the United States in a very transparent and patient-focused manner. QC Kinetix is an opportunity to become the first option when dealing with pain, not the alternative to those ways. That is our mission over time.”
QC Kinetix Brings A Patient-Centered Approach To Treatment
QC Kinetix is a leader in regenerative medicine and is helping people maintain their active lifestyles by using comprehensive regenerative medicine treatments to address musculoskeletal and joint pain.
They have successfully treated thousands of patients using unique biologics treatment protocols.
QC Kinetix uses the body’s own healing properties through state-of-the-art natural biologic treatments as alternatives to invasive surgery and addictive pain medications.
The clinics are dedicated to maximizing the body’s ability to help heal and repair itself from the inside out for vastly improved function and overall quality of life.
Patients might come in with knee, shoulder or hip pain. QC Kinetix treatments use someone’s natural body properties to regenerate health. The company has hit many milestones since being founded.
In 2023, QC Kinetix hit over $100 million in system-wide sales, and in April 2024, the company served their 40,000th patient since beginning the nationwide expansion in 2021.
“It is our goal to change medicine,” the CEO of QC Kenetix shared. “We want to be the first thing people think about when they or a loved one are dealing with pain. We measure that success by seeing feedback from our patients that we could change their lives. We aim to care for our patients and employees first, knowing that growth and profit will follow.”
QC Kinetix Is On The Edge of a Monumental Breakthrough
With a strong foothold in the United States, QC Kinetix is now setting its sights on international expansion. The brand is planning to enter the markets of the United Kingdom, Australia, and New Zealand in the coming years, further solidifying its position as a global leader in regenerative medicine.
QC Kinetix aims to hit 250 open locations in the United States by the end of 2024.
That’s a lot to digest in just four years of franchising. Still, the CEO of QC Kinetix said the only thing that surprises him about the company’s growth is that it has not gone faster, especially considering the demand for alternative treatments to pain medications and surgery. This rapid growth highlights the strong consumer demand for non-surgical pain relief alternatives and the significant interest among franchise investors and operators in the medical sector.
“I love this brand and our future,” the CEO of QC Kinetix said.. “It’s about impacting people’s lives and being a game-changer in the medical field.”